Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Transition to IRD maintenance after DRD induction significantly deepens response in transplant-ineligible NDMM: A prospective multicenter study

Qiuqing Xiang, Minqiu Lu, Bin Chu, Lei Shi, Shan Gao, Lijuan Fang, Mengzhen Wang, Shuangnian Xu, Yan Zhu, Li Wang, Junnan Li, Hua Xue, Li Li, Tingting Duan, Ting Zhang, Li Bao

Blood (2025) 146 (Supplement 1): 4059.

https://doi.org/10.1182/blood-2025-4059

Published: 2025

Journal Articles

Is autologous hematopoietic stem cell transplantation as consolidation therapy superior to chemotherapy alone in newly diagnosed intermediate-high risk DLBCL patients?

Shuozi Liu, Lan Ma, Hui Liu, Jiefei Bai, Wenrong Huang, JunLi Chen, Li Bao, Shan Gao, Wanling Sun, Zhenling Li, Min Wang, Hongmei Jing

Blood (2025) 146 (Supplement 1): 1888.

https://doi.org/10.1182/blood-2025-1888

Published: 2025

Journal Articles

A Phase I Study of a Novel BCMA×CD3 Bispecific Antibody Emb-06 in Relapsed or Refractory Multiple Myeloma

Blood (2024) 144 (Supplement 1): 498.

https://doi.org/10.1182/blood-2024-193738

Published: 2024

Journal Articles

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT ± MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Label, Multicenter Clinical Trial

Rong Fu, Jia Song, Hui Liu, Zongjiu Jiao, Da Gao, Kai Ding, Jie Zhuo, Huijuan Jiang, Shan Gao, Yue Ren, Lijuan Li, Yihao Wang

Blood (2024) 144 (Supplement 1): 7786.

https://doi.org/10.1182/blood-2024-209056

Published: 2024

Journal Articles

Comparison of the Efficacy and Safety of Pegylated Interferon Alpha-2b and Common Interferon Alpha in Patients with Myeloproliferative Neoplasms

Guangshuai Teng, Yuhui Zhang, Chenxiao Du, Yan Wang, Naibo Hu, Yingdi Han, Jinyu Ma, Shan Gao, Guangpeng Xiang, Zonghong Shao, Jie Bai

Blood (2022) 140 (Supplement 1): 3959–3960.

https://doi.org/10.1182/blood-2022-168424

Published: 2022

Journal Articles

Validation of the Impede VTE Score for Prediction of Venous Thromboembolism in Chinese Patients with Multiple Myeloma: A Retrospective Cohort Study

Li Bao, Yu-Tong Wang, Min-qiu Lu, Junling Zhuang, Bin Chu, Lei Shi, Shan Gao, Li-juan Fang, Qiu-qing Xiang, Xi Liu, Yue-hua Ding, Kai Sun

Blood (2022) 140 (Supplement 1): 5146–5147.

https://doi.org/10.1182/blood-2022-168633

Published: 2022

Journal Articles

Mild Fibrosis (MF-1) Increases the Risk of Secondary Cancers in Patients with Myeloproliferative Neoplasms-Clinical Characteristics of 1060 Myeloproliferative Neoplasms Patients with Secondary Cancers

Yuhui Zhang, Yingdi Han, Guangshuai Teng, Chenxiao Du, Shan Gao, Weiping Yuan, Lei Zhang, Jie Bai

Blood (2022) 140 (Supplement 1): 9731–9732.

https://doi.org/10.1182/blood-2022-168376

Published: 2022

Journal Articles

ASXL1 Is a Risk Factor for Thrombosis in Polycythemia Vera

Yuhui Zhang, Guangshuai Teng, Chenxiao Du, Yan Wang, Naibo Hu, Yingdi Han, Jinyu Ma, Shan Gao, Guangpeng Xiang, Zonghong Shao, Jie Bai

Blood (2022) 140 (Supplement 1): 12167–12168.

https://doi.org/10.1182/blood-2022-166476

Published: 2022

Journal Articles

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT±MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial

Jia Song, Hui Liu, Zongjiu Jiao, Da Gao, Kai Ding, Yihao Wang, Hong Yu, Yuanyuan Shao, Huijuan Jiang, Shan Gao, Lijuan Li, Rong Fu, Zonghong Shao

Blood (2022) 140 (Supplement 1): 3739–3740.

https://doi.org/10.1182/blood-2022-164677

Published: 2022

Journal Articles

Vitro Culture and Regulation Of Osteoblasts and Cellular Immunity Function In Multiple Myeloma patients

Rong Fu, MD, Shan Gao, MD, Zonghong Shao, MD

Blood (2013) 122 (21): 5329.

https://doi.org/10.1182/blood.V122.21.5329.5329

Published: 2013

Journal Articles

Potentiation of Reactive Oxygen Species Is a Marker for Synergistic Cytotoxicity of MS-275 and 5-Azacytidine in Leukemic Cells.

Shan Gao, Claudia Miller, Jessica Boklan, Joya Chandra

Blood (2007) 110 (11): 4343.

https://doi.org/10.1182/blood.V110.11.4343.4343

Published: 2007

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Transition to IRD maintenance after DRD induction significantly deepens response in transplant-ineligible NDMM: A prospective multicenter study

Is autologous hematopoietic stem cell transplantation as consolidation therapy superior to chemotherapy alone in newly diagnosed intermediate-high risk DLBCL patients?

A Phase I Study of a Novel BCMA×CD3 Bispecific Antibody Emb-06 in Relapsed or Refractory Multiple Myeloma

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT ± MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Label, Multicenter Clinical Trial

Comparison of the Efficacy and Safety of Pegylated Interferon Alpha-2b and Common Interferon Alpha in Patients with Myeloproliferative Neoplasms

Validation of the Impede VTE Score for Prediction of Venous Thromboembolism in Chinese Patients with Multiple Myeloma: A Retrospective Cohort Study

Mild Fibrosis (MF-1) Increases the Risk of Secondary Cancers in Patients with Myeloproliferative Neoplasms-Clinical Characteristics of 1060 Myeloproliferative Neoplasms Patients with Secondary Cancers

ASXL1 Is a Risk Factor for Thrombosis in Polycythemia Vera

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT±MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial

Vitro Culture and Regulation Of Osteoblasts and Cellular Immunity Function In Multiple Myeloma patients

Potentiation of Reactive Oxygen Species Is a Marker for Synergistic Cytotoxicity of MS-275 and 5-Azacytidine in Leukemic Cells.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only